Quick Search

 

 


 

 

Result Summary for 107682_HPV

Result Summary
Protocol ID: 107682_HPV
Clinical Study ID: 107682_HPV-018
Official Title: A randomized, open study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals’ HPV vaccine Co-administered intramuscularly with Boostrix® and/or Menactra™ in healthy female subjects aged 11–18 years.
Phase: Phase 3
Study Indications or Diseases:
  • Diphtheria, Tetanus, Pertussis
  • Hepatitis A, Human Papillomavirus (HPV)
Generic Name: Human Papillomavirus Types 16 and 18 Vaccine
Trade/Product Name: Cervarix;Cervarix
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.